Literature DB >> 23372525

Osteoarthritis: The Rheumatologist's Perspective.

Marc C Hochberg1.   

Abstract

Entities:  

Keywords:  Anesthesiology; Imaging / Radiology; Medicine & Public Health; Orthopedics; Rheumatology; Sports Medicine; Surgical Orthopedics; mortality; osteoarthritis; pain; treatment

Year:  2011        PMID： 23372525      PMCID： PMC3295955          DOI： 10.1007/s11420-011-9253-9

Source DB:  PubMed          Journal:  HSS J        ISSN： 1556-3316


× No keyword cloud information.
  9 in total

1.  Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.

Authors: 
Journal:  Arthritis Rheum       Date:  2000-09

2.  The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.

Authors:  L Gossec; S Paternotte; J F Maillefert; C Combescure; P G Conaghan; A M Davis; K-P Gunther; G Hawker; M Hochberg; J N Katz; M Kloppenburg; K Lim; L S Lohmander; N N Mahomed; L March; K Pavelka; L Punzi; E M Roos; L Sanchez-Riera; J A Singh; M E Suarez-Almazor; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

3.  Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.

Authors:  Elena Losina; Rochelle P Walensky; William M Reichmann; Holly L Holt; Hanna Gerlovin; Daniel H Solomon; Joanne M Jordan; David J Hunter; Lisa G Suter; Alexander M Weinstein; A David Paltiel; Jeffrey N Katz
Journal:  Ann Intern Med       Date:  2011-02-15       Impact factor: 25.391

4.  OARSI-FDA initiative: defining the disease state of osteoarthritis.

Authors:  N E Lane; K Brandt; G Hawker; E Peeva; E Schreyer; W Tsuji; M C Hochberg
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

5.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

Review 6.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2008-02       Impact factor: 6.576

Review 7.  Mortality in osteoarthritis.

Authors:  M C Hochberg
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473

8.  Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients.

Authors:  Jonathan Skinner; James N Weinstein; Scott M Sporer; John E Wennberg
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

9.  All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study.

Authors:  Eveline Nüesch; Paul Dieppe; Stephan Reichenbach; Susan Williams; Samuel Iff; Peter Jüni
Journal:  BMJ       Date:  2011-03-08
  9 in total
  3 in total

1.  Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.

Authors:  Ruina Kong; Jie Gao; Yanhui Si; Dongbao Zhao
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

2.  Biotechnological Chondroitin a Novel Glycosamminoglycan With Remarkable Biological Function on Human Primary Chondrocytes.

Authors:  Antonietta Stellavato; Virginia Tirino; Francesca de Novellis; Antonella Della Vecchia; Fabio Cinquegrani; Mario De Rosa; Gianpaolo Papaccio; Chiara Schiraldi
Journal:  J Cell Biochem       Date:  2016-05-11       Impact factor: 4.429

3.  Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial.

Authors:  Jianping Wang
Journal:  J Int Med Res       Date:  2017-08-25       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.